Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionAllstate Corp
Latest Disclosed Ownership70,092 shares
Latest Disclosed Value $ 5,612,967
Allstate Corp reports 60.76% increase in ownership of EW / Edwards Lifesciences Corporation

On May 11, 2026 - Allstate Corp filed a 13F-HR form disclosing ownership of 70,092 shares of Edwards Lifesciences Corporation (MX:EW) valued at $5,612,967 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 43,601 shares of Edwards Lifesciences Corporation. This represents a change in shares of 60.76% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 70,092 26,491 60.76 5,613 51.02 0.0555
2026-02-09 2025-12-31 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 43,601 22,511 106.74 3,717 126.59 0.0508
2025-10-29 2025-09-30 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 21,090 21,090 1,640 0.0374
2025-08-05 2025-06-30 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 0 -16,747 -100.00 0 -100.00
2025-05-14 2025-03-31 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 16,747 -1,028 -5.78 1,214 -7.76 0.0357
2025-02-12 2024-12-31 13F EDWARDS LIFESCIENCES ORD Equity 28176E108 17,775 17,775 1,316 0.0388
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES EQU 28176E108 0 -2,618 -100.00 0 -100.00
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES EQU 28176E108 2,618 0 0.00 247 13.89 0.0157
2023-05-10 2023-03-31 13F EDWARDS LIFESCIENCES EQU 28176E108 2,618 -17,681 -87.10 217 -85.73 0.0161
2023-02-14 2022-12-31 13F EDWARDS LIFESCIENCES EQU 28176E108 20,299 -7,300 -26.45 1,515 -33.63 0.0461
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES EQU 28176E108 27,599 281 1.03 2,281 -12.20 0.0656
2022-08-15 2022-06-30 13F EDWARDS LIFESCIENCES EQU 28176E108 27,318 6,469 31.03 2,598 5.87 0.0800
2022-05-16 2022-03-31 13F EDWARDS LIFESCIENCES EQU 28176E108 20,849 -26,914 -56.35 2,454 -60.34 0.0655
2022-02-15 2021-12-31 13F EDWARDS LIFESCIENCES EQU 28176E108 47,763 27,311 133.54 6,188 167.30 0.1182
2021-11-15 2021-09-30 13F EDWARDS LIFESCIENCES EQU 28176E108 20,452 -917 -4.29 2,315 4.61 0.0957
2021-08-16 2021-06-30 13F EDWARDS LIFESCIENCES EQU 28176E108 21,369 -814 -3.67 2,213 19.30 0.0742
2021-05-14 2021-03-31 13F EDWARDS LIFESCIENCES EQU 28176E108 22,183 537 2.48 1,855 -6.08 0.0582
2021-02-12 2020-12-31 13F EDWARDS LIFESCIENCES EQU 28176E108 21,646 -2,638 -10.86 1,975 1.91 0.0613
2020-11-13 2020-09-30 13F EDWARDS LIFESCIENCES EQU 28176E108 24,284 -1,013 -4.00 1,938 10.87 0.0629
2020-08-13 2020-06-30 13F EDWARDS LIFESCIENCES EQU 28176E108 25,297 15,869 168.32 1,748 -1.69 0.0601
2020-05-15 2020-03-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 9,428 -11,645 -55.26 1,778 -63.83 0.0696
2020-02-14 2019-12-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 21,073 50 0.24 4,916 6.34 0.0892
2019-11-14 2019-09-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 21,023 0 0.00 4,623 19.03 0.0795
2019-08-14 2019-06-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 21,023 2,444 13.15 3,884 9.25 0.0694
2019-05-20 2019-03-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 18,579 9 0.05 3,555 25.00 0.0958
2019-02-13 2018-12-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 18,570 18,570 2,844 0.0934
2016-11-14 2016-09-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 0 -40,386 -100.00 0 -100.00
2016-08-11 2016-06-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 40,386 0 0.00 4,028 13.08 0.2635
2016-05-16 2016-03-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 40,386 -381 -0.93 3,562 10.62 0.3071
2016-02-16 2015-12-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 40,767 23,567 137.02 3,220 31.70 0.3065
2015-11-16 2015-09-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 17,200 0 0.00 2,445 -0.20 0.2518
2015-08-13 2015-06-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 17,200 -89,722 -83.91 2,450 -65.15 0.2184
2014-02-14 2013-12-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 106,922 106,922 7,031 0.2606
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.